Scholars Central

Conference abstractPublished 26 Oct 2015

Biosimilars: Is the risk worth the reward?

Authors: James Harris III

Healthcare Economics LLC, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The presentation will cover assessing the promise and potential of biosimilars with respect to commercialization and marketing considerations to maximize market share. Recent commercial developments will also be discussed as well as provider and payer perspectives with regard to biosimilar acceptance.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “James Harris III”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels